{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:42:03Z","timestamp":1790336523737,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Indoxyl sulfate, a nephrovascular uremic toxin, is markedly accumulated in the serum of chronic kidney disease (CKD) patients. Because of its protein binding ability, its removal by hemodialysis is not as efficient as that of non\u2010protein bound uremic toxins. AST\u2010120 delays the progression of CKD by adsorbing indole, a precursor of indoxyl sulfate, in the intestines, and consequently reduces the serum levels of indoxyl sulfate. Indoxyl sulfate exhibits cellular toxicity in renal tubular cells, glomerular mesangial cells, vascular smooth muscle cells, vascular endothelial cells, cardiac myocytes, and osteoblasts by inducing oxidative stress. Indoxyl sulfate stimulates the progression of CKD by increasing the expression of fibrogenic genes such as transforming growth factor\u2010\u03b21 in CKD rats. Indoxyl sulfate stimulates aortic calcification in hypertensive rats; thus, indoxyl sulfate is involved in the progression of CKD and cardiovascular disease. Experimental and clinical data demonstrate that AST\u2010120 delays the progression not only of chronic kidney disease, but also of cardiovascular disease.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2010.00882.x","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T09:19:35Z","timestamp":1295947175000},"page":"120-124","source":"Crossref","is-referenced-by-count":108,"title":["Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST\u2010120"],"prefix":"10.1111","volume":"15","author":[{"given":"Toshimitsu","family":"Niwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa T","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"62","key":"e_1_2_7_3_2","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF\u2010\u03b21, TIMP\u20101 and pro\u03b11(I) collagen in kidneys of uremic rats","volume":"52","author":"Miyazaki T","year":"1997","journal-title":"Kidney Int"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm861"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi901786x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.2.105"},{"issue":"62","key":"e_1_2_7_7_2","first-page":"S23","article-title":"The protein metabolite hypothesis, a model for the progression of renal failure: an oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients","volume":"52","author":"Niwa T","year":"1997","journal-title":"Kidney Int"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1773"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2006.10.007"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2007.10.013"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000264634"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000313491"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00175.2010"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00659.2009"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl311"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2008.29"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp007"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.12.036"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-006-0441-8"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000097985"},{"key":"e_1_2_7_21_2","first-page":"213","article-title":"An oral adsorbent, AST\u2010120, combined with a low\u2010protein diet and RAS blocker, for chronic kidney disease","volume":"21","author":"Yorioka N","year":"2008","journal-title":"J Nephrol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.04.024"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.05.011"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00430.x"},{"key":"e_1_2_7_25_2","article-title":"Oral adsorbent AST\u2010120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation","author":"Nakamura T","year":"2010","journal-title":"Metabolism"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000077536"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/08860220802356531"},{"key":"e_1_2_7_28_2","first-page":"535","article-title":"Cardiorenal protective effect of the oral uremic toxin absorbent AST\u2010120 in chronic heart disease patients with moderate CKD","volume":"23","author":"Shibahara H","year":"2010","journal-title":"J Nephrol"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2010.00882.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2010.00882.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T06:37:10Z","timestamp":1697265430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2010.00882.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1744-9987.2010.00882.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2010.00882.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}